VA's road from research to routine mental-health care
The VA uses a multi-step, evidence-based process to turn new mental-health treatments into standard care, weighing research quality, patient safety, ethics, staffing, and resources—and FDA approval alone isn’t enough. Through a team-driven rollout (not a single office), treatments like rTMS are piloted in veterans, studied across facilities, and expanded before becoming routine; medications go through the National Formulary with use criteria. Emerging therapies (ketamine, cannabis, psychedelics) are approached cautiously within ongoing trials. Even after adoption, safety monitoring and guideline updates continue, and veterans may see treatments as available, restricted, or trial-based depending on evidence and logistics.
